Tens of thousands of people being treated for AIDS will suffer if Swiss pharmaceutical company Novartis succeeds in changing India's patent law, the humanitarian agency Medecins Sans Frontieres warned on Monday.
Novartis is challenging a specific provision of India's patent law that, if overturned, would see patents being granted far more widely, heavily restricting the availability of affordable generic medicines, MSF says.
"If they hit India it basically cuts off the lifeline for generic medicines. They're going for the jugular," MSF spokesman James Lorenz added.
Read More
